Table 1. Clinicopathologic factors related to BRAF mutation in 1,199 patients with PTC.
| Clinicopathologic factors | BRAF (+) | BRAF (−) | χ2/t-test | P | Spearman | P |
|---|---|---|---|---|---|---|
| Age (years) | 791 | 408 | 0.608 | 0.436 | 0.099 | 0.001 |
| Mean ± SD | 43.8±12.0 | 46.7±13.0 | <0.001 | |||
| ≤45 | 433 | 180 | ||||
| >45 | 358 | 228 | ||||
| Sex | 791 | 408 | 268.1 | <0.001 | −0.052 | 0.074 |
| Male | 195 | 121 | ||||
| Female | 596 | 287 | ||||
| Tumor size (cm) | 888 | 427 | 22.2 | <0.001 | 0.031 | 0.264 |
| Mean ± SD | 0.82±0.49 | 0.86±0.56 | <0.001 | |||
| <1.0 | 688 | 320 | ||||
| ≥1.0 | 200 | 107 | ||||
| Multiplicity | 134.7 | <0.001 | 0.040 | 0.151 | ||
| Absent | 884 | 427 | ||||
| Present | 4 | 0 | ||||
| Bilaterality | 158.2 | <0.001 | 0.108 | 0.001 | ||
| Absent | 791 | 408 | ||||
| Present | 97 | 19 |
PTC, papillary thyroid carcinoma.